"Liver Cirrhosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Descriptor ID |
D008103
|
| MeSH Number(s) |
C06.552.630
|
| Concept/Terms |
Liver Cirrhosis- Liver Cirrhosis
- Cirrhosis, Liver
- Cirrhoses, Liver
- Liver Cirrhoses
- Hepatic Cirrhosis
- Cirrhoses, Hepatic
- Cirrhosis, Hepatic
- Hepatic Cirrhoses
|
Below are MeSH descriptors whose meaning is more general than "Liver Cirrhosis".
Below are MeSH descriptors whose meaning is more specific than "Liver Cirrhosis".
This graph shows the total number of publications written about "Liver Cirrhosis" by people in this website by year, and whether "Liver Cirrhosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1998 | 3 | 0 | 3 |
| 1999 | 2 | 0 | 2 |
| 2000 | 2 | 2 | 4 |
| 2001 | 3 | 2 | 5 |
| 2002 | 3 | 1 | 4 |
| 2003 | 3 | 2 | 5 |
| 2004 | 6 | 3 | 9 |
| 2005 | 6 | 1 | 7 |
| 2006 | 4 | 2 | 6 |
| 2007 | 2 | 2 | 4 |
| 2008 | 4 | 2 | 6 |
| 2009 | 6 | 3 | 9 |
| 2010 | 9 | 3 | 12 |
| 2011 | 17 | 8 | 25 |
| 2012 | 12 | 3 | 15 |
| 2013 | 17 | 1 | 18 |
| 2014 | 14 | 2 | 16 |
| 2015 | 15 | 9 | 24 |
| 2016 | 20 | 6 | 26 |
| 2017 | 21 | 9 | 30 |
| 2018 | 21 | 11 | 32 |
| 2019 | 21 | 8 | 29 |
| 2020 | 16 | 15 | 31 |
| 2021 | 15 | 26 | 41 |
| 2022 | 5 | 34 | 39 |
| 2023 | 2 | 37 | 39 |
| 2024 | 23 | 11 | 34 |
| 2025 | 24 | 1 | 25 |
| 2026 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver Cirrhosis" by people in Profiles.
-
Noninvasive Detection of Occult yet Significant Liver Pathology in Alanine Aminotransferase-Normal Chronic Hepatitis B: A Multicenter Study. J Infect Dis. 2026 Mar 17; 233(3):528-540.
-
Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis. Hepatol Commun. 2026 Mar 01; 10(3).
-
Assessment of non-invasive fibrosis scoring systems in pediatric MASLD: A retrospective comparison across healthy, MASLD, and biopsy-staged groups. Clin Chim Acta. 2026 Apr 15; 586:120905.
-
Evolving burden of metabolic dysfunction-associated steatotic liver disease and its complications in a US nationwide healthcare system. Hepatol Commun. 2026 Jan 01; 10(1).
-
Barriers to Medical Care Are Frequently Reported by Patients With Cirrhosis. Aliment Pharmacol Ther. 2026 Apr; 63(8):1162-1168.
-
Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease. J Gastrointestin Liver Dis. 2025 12 26; 34(4):437-450.
-
Serum N-glycomics for non-invasive detection of significant liver pathology across clinical phases of treatment-na?ve chronic hepatitis B. J Transl Med. 2025 Dec 25; 24(1):244.
-
Comparative Effectiveness and Safety of Various Anticoagulation Regimens for Portal Venous Thrombosis in Cirrhosis: A Systematic Review and Network Meta-Analysis. Clin Appl Thromb Hemost. 2025 Jan-Dec; 31:10760296251405419.
-
Selective inhibition of long isoforms of phosphodiesterase 4D mitigates liver fibrosis in mouse models. J Clin Invest. 2026 Jan 02; 136(1).
-
HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohort. J Hepatol. 2026 Mar; 84(3):578-586.